Inclusion completed

Open-label, uncontrolled phase II trial of intravenous PI3K inhibitor BAY-80-6946 in patients with relapsed, indolent or aggressive Non-Hodgkin´s lymphomas

Cancer type: Lymphoma

Phase: II

Principal Investigator: Leppä Sirpa

Country: FI

Keywords: Finland, Lymphoma

Status: Inclusion completed

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/record/NCT01660451